YUNG-TSU CHOLee, Fang-YuFang-YuLeeCHIA-YU CHUWang, Li-FangLi-FangWang2019-12-042019-12-042014-070001-5555https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902772670&doi=10.2340%2f00015555-1746&partnerID=40&md5=d9720ba81f3e87b6949931d46baff5f7https://scholars.lib.ntu.edu.tw/handle/123456789/434911en[SDGs]SDG3azathioprine; corticosteroid; prednisolone; rituximab; corticosteroid; immunosuppressive agent; monoclonal antibody; prednisolone; rituximab; absence of side effects; adult; aged; clinical article; corticosteroid therapy; disease severity; drug efficacy; drug safety; female; human; male; middle aged; note; pemphigus foliaceus; pemphigus vulgaris; priority journal; relapse; remission; treatment duration; treatment response; drug combination; immunology; pemphigus; retrospective study; severity of illness index; Taiwan; time; treatment outcome; Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Pemphigus; Prednisolone; Retrospective Studies; Severity of Illness Index; Taiwan; Time Factors; Treatment Outcomenote10.2340/00015555-1746242178212-s2.0-84902772670